Marco Rastrelli

Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.

Marco Rastrelli, Saveria Tropea, Carlo Riccardo Rossi et al. · PubMed · 2015 · 684 citations

Epidemiology Of Cancer, Pathology, Malignant Melanoma +16

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux et al. · The Lancet Oncology · 2020 · 446 citations · Full text

Surgical Oncology, Primary Retroperitoneal Sarcoma, Radiation Therapy +7

STRASS (EORTC 62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma.

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux et al. · Journal of Clinical Oncology · 2019 · 87 citations

Surgical Oncology, Colorectal Surgery, Multimodality +19

The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target

Maria Vittoria Enzo, Marco Rastrelli, Carlo Riccardo Rossi et al. · Molecular and Cellular Therapies · 2015 · 59 citations · Full text